StockData
INSMED Inc logo

INSMED Inc (INSM) stock

INSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/30100% above fair value
$122.88+1.72 (+1.42%)

Close on Nov 16, 2026Market cap $26.96BP/E –Yield –

Insmed total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Insmed's total debt was $555.09M at Sep 30, 2026. For fiscal 2025 it was $540.96M, down 51.0% from the year before. Over ten years it grew 35.9% a year on average. The highest annual figure on record is $1.16B in fiscal 2023.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$540.96M-51.0%
FY2024Dec 31, 2024$1.10B-4.5%
FY2023Dec 31, 2023$1.16B+2.7%
FY2022Dec 31, 2022$1.13B+98.6%
FY2021Dec 31, 2021$566.59M+59.0%
FY2020Dec 31, 2020$356.32M+6.1%
FY2019Dec 31, 2019$335.94M+6.1%
FY2018Dec 31, 2018$316.56M+469.7%
FY2017Dec 31, 2017$55.57M+1.4%
FY2016Dec 31, 2016$54.79M+117.9%
FY2015Dec 31, 2015$25.14M+1.1%
FY2014Dec 31, 2014$24.86M+26.7%
FY2013Dec 31, 2013$19.62M+48.5%
FY2012Dec 31, 2012$13.21M–
FY2011Dec 31, 2011$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$555.09M+2.8%
Q2 FY2026Jun 30, 2026$543.51M+0.9%
Q1 FY2026Mar 31, 2026$542.22M-50.9%
Q4 FY2025Dec 31, 2025$540.96M-51.0%
Q3 FY2025Sep 30, 2025$539.72M-43.5%
Q2 FY2025Jun 30, 2025$538.51M-54.0%
Q1 FY2025Mar 31, 2025$1.11B-5.0%
Q4 FY2024Dec 31, 2024$1.10B-4.5%
Q3 FY2024Sep 30, 2024$954.83M-16.8%
Q2 FY2024Jun 30, 2024$1.17B+2.8%
Q1 FY2024Mar 31, 2024$1.16B+2.7%
Q4 FY2023Dec 31, 2023$1.16B+2.7%
Q3 FY2023Sep 30, 2023$1.15B+46.2%
Q2 FY2023Jun 30, 2023$1.14B+45.4%
Q1 FY2023Mar 31, 2023$1.13B+44.6%
Q4 FY2022Dec 31, 2022$1.13B+98.6%
Q3 FY2022Sep 30, 2022$784.80M+40.7%
Q2 FY2022Jun 30, 2022$783.98M+42.9%
Q1 FY2022Mar 31, 2022$783.16M+116.6%
Q4 FY2021Dec 31, 2021$566.59M+59.0%
Q3 FY2021Sep 30, 2021$557.60M+58.8%
Q2 FY2021Jun 30, 2021$548.75M+58.6%
Q1 FY2021Mar 31, 2021$361.58M+6.1%
Q4 FY2020Dec 31, 2020$356.32M+6.1%
Q3 FY2020Sep 30, 2020$351.13M+6.1%
Q2 FY2020Jun 30, 2020$346.00M+6.1%
Q1 FY2020Mar 31, 2020$340.94M+6.1%
Q4 FY2019Dec 31, 2019$335.94M+6.1%
Q3 FY2019Sep 30, 2019$331.00M+6.1%
Q2 FY2019Jun 30, 2019$326.13M+6.2%
Q1 FY2019Mar 31, 2019$321.31M+6.1%
Q4 FY2018Dec 31, 2018$316.56M+469.7%
Q3 FY2018Sep 30, 2018$311.86M+463.0%
Q2 FY2018Jun 30, 2018$307.16M+456.5%
Q1 FY2018Mar 31, 2018$302.71M+450.4%
Q4 FY2017Dec 31, 2017$55.57M+1.4%
Q3 FY2017Sep 30, 2017$55.39M–
Q2 FY2017Jun 30, 2017$55.19M–
Q1 FY2017Mar 31, 2017$54.99M–
Q4 FY2016Dec 31, 2016$54.79M–

More Insmed figures

See a number that looks wrong?